EDN1 and cardiac hypertrophy: Fenofibrate treatment prevents cardiac hypertrophy by decreasing the expression of ET-1 mRNA, as well as collagen type I and type III mRNA in a pressure-overload model in rats by abdominal aorta banding [49].